Australia markets open in 2 hours 28 minutes

Oscar Health, Inc. (OSCR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
17.42-0.05 (-0.29%)
At close: 04:00PM EDT
17.30 -0.12 (-0.69%)
After hours: 05:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.23B
Enterprise value 2.26B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.63
Price/book (mrq)3.71
Enterprise value/revenue 0.31
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3168.77%
S&P500 52-week change 322.62%
52-week high 323.44
52-week low 34.72
50-day moving average 316.94
200-day moving average 315.26

Share statistics

Avg vol (3-month) 32.98M
Avg vol (10-day) 32.01M
Shares outstanding 5206.4M
Implied shares outstanding 6241.91M
Float 8184.75M
% held by insiders 12.79%
% held by institutions 184.57%
Shares short (15 Aug 2024) 417.68M
Short ratio (15 Aug 2024) 45.78
Short % of float (15 Aug 2024) 48.95%
Short % of shares outstanding (15 Aug 2024) 47.31%
Shares short (prior month 15 July 2024) 414.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.25%
Operating margin (ttm)3.06%

Management effectiveness

Return on assets (ttm)0.04%
Return on equity (ttm)1.74%

Income statement

Revenue (ttm)7.23B
Revenue per share (ttm)31.43
Quarterly revenue growth (yoy)45.90%
Gross profit (ttm)N/A
EBITDA 35.69M
Net income avi to common (ttm)18.15M
Diluted EPS (ttm)-0.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.63B
Total cash per share (mrq)10.89
Total debt (mrq)363.84M
Total debt/equity (mrq)31.90%
Current ratio (mrq)0.96
Book value per share (mrq)4.72

Cash flow statement

Operating cash flow (ttm)279.12M
Levered free cash flow (ttm)1.15B